SEMA4

Serial Number 86983080
Registration 5330559
704

Registration Progress

Application Filed
Jun 11, 2015
Under Examination
Approved for Publication
Published for Opposition
Jan 19, 2016
Registered
Nov 7, 2017

Trademark Image

SEMA4

Basic Information

Serial Number
86983080
Registration Number
5330559
Filing Date
June 11, 2015
Registration Date
November 7, 2017
Published for Opposition
January 19, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
704
Status Date
Jan 30, 2025
Registration
Registered
Classes
001 005 035 042
+1 more

Rights Holder

SEMA4 OPCO, INC.

03
Address
333 Ludlow Street
North Tower, 6th Floor
Stamford, CT 06902

Ownership History

Icahn School of Medicine at Mount Sinai

Original Applicant
99
New York, NY

Icahn School of Medicine at Mount Sinai

Owner at Publication
99
New York, NY

MOUNT SINAI GENOMICS, INC.

New Owner After Publication #1
03
NEW YORK, NY

MOUNT SINAI GENOMICS, INC.

Original Registrant
03
NEW YORK, NY

SEMA4 OPCO, INC.

New Owner After Registration #1
03
Stamford, CT

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

Next Deadline
832 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-11-07)
Due Date
November 07, 2027
Grace Period Ends
May 07, 2028

Application History

50 events
Date Code Type Description Documents
May 1, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 1, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 1, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 30, 2025 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
Jan 30, 2025 8.PR O REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED Loading...
Jan 30, 2025 PRAN O POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED Loading...
Jan 30, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Oct 28, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 28, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 28, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 28, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 28, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 28, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
May 7, 2024 ES8R I TEAS SECTION 8 RECEIVED Loading...
Nov 8, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Nov 7, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
May 10, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 10, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 10, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 4, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 7, 2018 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
May 7, 2018 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Dec 27, 2017 PRAM O POST REGISTRATION ACTION MAILED - SEC. 7 Loading...
Dec 27, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 27, 2017 FAXX I FAX RECEIVED Loading...
Nov 20, 2017 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Nov 7, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 30, 2017 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 29, 2017 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 13, 2017 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 13, 2017 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Sep 11, 2017 IUAF S USE AMENDMENT FILED Loading...
Sep 11, 2017 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Sep 11, 2017 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Sep 11, 2017 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 30, 2017 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 17, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 15, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 15, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 15, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 30, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 28, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 20, 2016 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Oct 20, 2016 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Oct 20, 2016 PETG O PETITION TO REVIVE-GRANTED Loading...
Oct 20, 2016 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Oct 20, 2016 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 17, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Oct 17, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...

Detailed Classifications

Class 001
[ Kits containing chemical and biochemical assays and reagents for scientific research use; nucleic acid and protein isolation kits comprised primarily of assays and reagents for use in epigenetic research and analysis; none of the aforementioned involve the use or study of semaphorins ]
First Use Anywhere: May 1, 2017
First Use in Commerce: May 1, 2017
Class 005
[ Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, namely, cancer and Mendelian disorders; test kits consisting of medical diagnostic reagents and assays for testing in the field of the prevention and treatment of disorders and diseases; none of the aforementioned involve the use or study of semaphorins ]
First Use Anywhere: May 1, 2017
First Use in Commerce: May 1, 2017
Class 035
[ Business consulting and business information services regarding precision health diagnosis and personalized treatment; business consulting and business information services regarding the analysis and packaging of health data; providing business information, namely, commercial corporate and statistical information provided on-line from a computer database or the Internet; statistical analysis and reporting services for business purposes; business consulting and business information services regarding the identification of drug targets; business consulting and business information services regarding bioinformatic analysis; population health management ]
First Use Anywhere: May 1, 2017
First Use in Commerce: May 1, 2017
Class 042
[ Medical and scientific research in the field of biologic testing and interpretation, diagnosis, treatment, and health maintenance; bioinformatics interpretation of health data; medical and scientific research in the field of ancestry analysis for scientific research purposes; compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; analysis and screening of nucleic acids for scientific research purposes; genome mapping for scientific purposes; ] providing information in the field of disease classification for use in connection with diagnostic testing [; development of scientific research and technology for purposes of disease diagnosis, preventative health care, health monitoring, and personalized treatment; providing a website featuring non-downloadable software for patient access to health care services and health information; providing a website featuring non-downloadable software for patient access to diagnosis, treatment, and health maintenance information; providing a website featuring non-downloadable software for accessing, viewing, interacting with and downloading personal health records, diagnoses, treatment plans, and health monitoring information; scientific and medical research, namely, identifying drug targets; scientific research relating to population health management; none of the aforementioned involve the use or study of semaphorins ]
First Use Anywhere: May 1, 2017
First Use in Commerce: May 1, 2017
Class 044
Diagnostic services in the field of medicine; medical testing for diagnosis of diseases and treatment purposes [; bioinformatics analysis for medical diagnostic and personalized treatment purposes; biochemical testing for ancestry analysis and personalized diagnostics and treatments; nucleic acid analysis and screening for medical diagnostic and treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; health care services, namely, leveraging health monitoring and data science to provide optimal health and disease prevention to patients; creating personalized preventative health-care programs and disease management programs; providing an online resource center featuring personalized health information based on health information and diagnostics; medical testing, namely, identifying drug targets for diagnostic or treatment purposes; none of the aforementioned involve the use or study of semaphorins ]
First Use Anywhere: May 1, 2017
First Use in Commerce: May 1, 2017

Additional Information

Other
In the statement, Column 1, line 1, "New York" should be deleted, and Delaware should be inserted.
Pseudo Mark
SEMA FOUR

Classification

International Classes
001 005 035 042 044